C19H17F3N2O4S
Neat
426.41
Room Temperature
Fevipiprant; 872365-14-5; NVP-QAW039; QAW039; 2PEX5N7DQ4; QAW-039; DTXSID501336031; (1-(4-((Methane)sulfonyl)-2-trifluoromethylbenzyl)-2-methyl-1H-pyrrolo(2, 3-b)pyridin-3-yl)acetic acid; 2-(1-((4-Methanesulfonyl-2-(trifluoromethyl)phenyl)methyl(-2-methyl-1H-pyrrolo(2, 3-b)pyridin-3-yl)acetic acid; 1-(4-methanesulfonylbenzyl)-2-methyl-1H-pyrrolo(2, 3-b)pyridin-3-yl)acetic acid; 2-(1-{[4-methanesulfonyl-2-(trifluoromethyl)phenyl]methyl}-2-methyl-1H-pyrrolo[2, 3-b]pyridin-3-yl)acetic acid; fevipiprantum; 2-(1-((4-methanesulfonyl-2-(trifluoromethyl)phenyl)methyl)-2-methyl-1H-pyrrolo(2, 3-b)pyridin-3-yl)acetic acid; 2-(2-methyl-1-((4-methylsulfonyl-2-(trifluoromethyl)phenyl)methyl)pyrrolo(5, 4-b)pyridin-3-yl)acetic acid; 2-[2-methyl-1-[[4-methylsulfonyl-2-(trifluoromethyl)phenyl]methyl]pyrrolo[5, 4-b]pyridin-3-yl]acetic acid; RefChem:599177; DTXCID401766118; Fevipiprant [INN]; 2-(2-methyl-1-(4-(methylsulfonyl)-2-(trifluoromethyl)benzyl)-1H-pyrrolo[2 and 3-b]pyridin-3-yl)acetic acid; MFCD22548206
2-[2-methyl-1-[[4-methylsulfonyl-2-(trifluoromethyl)phenyl]methyl]pyrrolo[2 and 3-b]pyridin-3-yl]acetic acid
InChI=1S/C19H17F3N2O4S/c1-11-15(9-17(25)26)14-4-3-7-23-18(14)24(11)10-12-5-6-13(29(2,27)28)8-16(12)19(20,21)22/h3-8H,9-10H2,1-2H3,(H,25,26)